238 related articles for article (PubMed ID: 31171783)
1. Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice.
Gamache J; Benzow K; Forster C; Kemper L; Hlynialuk C; Furrow E; Ashe KH; Koob MD
Nat Commun; 2019 Jun; 10(1):2479. PubMed ID: 31171783
[TBL] [Abstract][Full Text] [Related]
2. Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model.
Bailey RM; Howard J; Knight J; Sahara N; Dickson DW; Lewis J
Mol Neurodegener; 2014 Jan; 9():8. PubMed ID: 24428919
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy.
Takaichi Y; Chambers JK; Inoue H; Ano Y; Takashima A; Nakayama H; Uchida K
Acta Neuropathol Commun; 2020 Jun; 8(1):86. PubMed ID: 32560668
[TBL] [Abstract][Full Text] [Related]
4. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
5. Deposition of Phosphorylated α-Synuclein in the rTg4510 Mouse Model of Tauopathy.
Takaichi Y; Ano Y; Chambers JK; Uchida K; Takashima A; Nakayama H
J Neuropathol Exp Neurol; 2018 Oct; 77(10):920-928. PubMed ID: 30107539
[TBL] [Abstract][Full Text] [Related]
6. Differential accumulation of tau pathology between reciprocal F1 hybrids of rTg4510 mice.
Yanagisawa D; Hamezah HS; Pahrudin Arrozi A; Tooyama I
Sci Rep; 2021 May; 11(1):9623. PubMed ID: 33953293
[TBL] [Abstract][Full Text] [Related]
7. Study of tau pathology in male rTg4510 mice fed with a curcumin derivative Shiga-Y5.
Yanagisawa D; Hamezah HS; Durani LW; Taguchi H; Tooyama I
PLoS One; 2018; 13(12):e0208440. PubMed ID: 30521594
[TBL] [Abstract][Full Text] [Related]
8. Cornel Iridoid Glycoside Suppresses Tau Hyperphosphorylation and Aggregation in a Mouse Model of Tauopathy through Increasing Activity of PP2A.
Ma D; Luo Y; Huang R; Zhao Z; Wang Q; Li L; Zhang L
Curr Alzheimer Res; 2019; 16(14):1316-1331. PubMed ID: 31902362
[TBL] [Abstract][Full Text] [Related]
9. Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy.
Wang X; Smith K; Pearson M; Hughes A; Cosden ML; Marcus J; Hess JF; Savage MJ; Rosahl T; Smith SM; Schachter JB; Uslaner JM
PLoS One; 2018; 13(4):e0195486. PubMed ID: 29624602
[TBL] [Abstract][Full Text] [Related]
10. Cornel Iridoid Glycoside Suppresses Hyperactivity Phenotype in rTg4510 Mice through Reducing Tau Pathology and Improving Synaptic Dysfunction.
Ma DL; Luo Y; Huang R; Zhao ZR; Zhang L; Li YL; Wang Q; Li L; Zhang L
Curr Med Sci; 2020 Dec; 40(6):1031-1039. PubMed ID: 33428130
[TBL] [Abstract][Full Text] [Related]
11. Progressive Pathological Changes in Neurochemical Profile of the Hippocampus and Early Changes in the Olfactory Bulbs of Tau Transgenic Mice (rTg4510).
Kim J; Choi IY; Duff KE; Lee P
Neurochem Res; 2017 Jun; 42(6):1649-1660. PubMed ID: 28523532
[TBL] [Abstract][Full Text] [Related]
12. TAPPing into the potential of inducible tau/APP transgenic mice.
Xu G; Ulm BS; Howard J; Fromholt SE; Lu Q; Lee BB; Walker A; Borchelt DR; Lewis J
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12791. PubMed ID: 35067965
[TBL] [Abstract][Full Text] [Related]
13. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
14. Endogenous tau aggregates in oligodendrocytes of rTg4510 mice induced by human P301L tau.
Ren Y; Lin WL; Sanchez L; Ceballos C; Polydoro M; Spires-Jones TL; Hyman BT; Dickson DW; Sahara N
J Alzheimers Dis; 2014; 38(3):589-600. PubMed ID: 24028867
[TBL] [Abstract][Full Text] [Related]
15. Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy.
Blackmore T; Meftah S; Murray TK; Craig PJ; Blockeel A; Phillips K; Eastwood B; O'Neill MJ; Marston H; Ahmed Z; Gilmour G; Gastambide F
Alzheimers Res Ther; 2017 Sep; 9(1):77. PubMed ID: 28931441
[TBL] [Abstract][Full Text] [Related]
16. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology.
Song L; Lu SX; Ouyang X; Melchor J; Lee J; Terracina G; Wang X; Hyde L; Hess JF; Parker EM; Zhang L
Mol Neurodegener; 2015 Mar; 10():14. PubMed ID: 25881209
[TBL] [Abstract][Full Text] [Related]
17. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models.
Ni R; Ji B; Ono M; Sahara N; Zhang MR; Aoki I; Nordberg A; Suhara T; Higuchi M
J Nucl Med; 2018 Jun; 59(6):960-966. PubMed ID: 29419480
[TBL] [Abstract][Full Text] [Related]
18. MK-8719, a Novel and Selective
Wang X; Li W; Marcus J; Pearson M; Song L; Smith K; Terracina G; Lee J; Hong KK; Lu SX; Hyde L; Chen SC; Kinsley D; Melchor JP; Rubins DJ; Meng X; Hostetler E; Sur C; Zhang L; Schachter JB; Hess JF; Selnick HG; Vocadlo DJ; McEachern EJ; Uslaner JM; Duffy JL; Smith SM
J Pharmacol Exp Ther; 2020 Aug; 374(2):252-263. PubMed ID: 32493725
[TBL] [Abstract][Full Text] [Related]
19. Home cage measures of Alzheimer's disease in the rTg4510 mouse model.
Barabas AJ; Robbins LA; Gaskill BN
Genes Brain Behav; 2022 Feb; 21(2):e12795. PubMed ID: 35044727
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy.
Berger Z; Roder H; Hanna A; Carlson A; Rangachari V; Yue M; Wszolek Z; Ashe K; Knight J; Dickson D; Andorfer C; Rosenberry TL; Lewis J; Hutton M; Janus C
J Neurosci; 2007 Apr; 27(14):3650-62. PubMed ID: 17409229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]